TELO · Categories · Form 5

TELO - SEC Form 5 annual insider statements

Telomir Pharmaceuticals Inc. (TELO) sec form 5 annual insider statements - real-time wire coverage filtered to Form 5 only.

Recent Form 5 for TELO

• 496d
  Aminov Erez decreased direct ownership by 0.67% to 29,600 units (SEC Form 5)

  5 - Telomir Pharmaceuticals, Inc. (0001971532) (Issuer)

Other TELO categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 3
• DEF 14A
• M&A
• Earnings
• Dividends